Author:
Nardi Antonio,Olesen Søren-Peter,Christophersen Palle
Publisher
Springer International Publishing
Reference317 articles.
1. Adorante JS, Woldemussie E, Ruiz G (1996) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers. WO 1996033719
2. Agarwal JJ, Zhu Y, Zhang QY, Mongin AA, Hough LB (2013) TRAM-34, a putatively selective blocker of intermediate-conductance, calcium-activated potassium channels, inhibits cytochrome P450 activity. PLoS One 8(5):e63028
3. Aihara H, Hosaka T, Kashiwagi T, Kohnomi S, Kono RTCC (2004) Calcium-activated K channel activator EP 1400243
4. Akada K, Izumi S, Yasuura H (2002) Sustained release oral preparations WO 2001070221
5. Albaqumi M, Srivastava S, Li Z, Zhdnova O, Wulff H, Itani O, Wallace DP, Skolnik EY (2008) KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease. Kidney Int 74(6):740–749
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献